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Many stillbirths result from pregnancy complications,
whose root cause is abnormal development and function
of the placenta [1]. In order to prevent stillbirths, we
need to have a better understanding of how the human
placenta develops, both in normal and abnormal preg-
nancies. This lack of understanding of the human pla-
centa has recently been acknowledged, and “The
Human Placenta Project” launched, by the National
Institute of Child Health and Human Development
(NICHD) [2]. In fact, the human placenta is difficult to
study because of the lack of both “in vivo” animal mod-
els and placental cell lines able to be cultured “in vitro”
in a tissue culture dish. Specifically, mice and rats have
placentas which differ from the human both in structure
and at the molecular level [3]; in addition, the human
placental cell lines behave differently in culture, com-
pared to the placental cells as they exist “in vivo” in the
pregnant patient [4]. Over the last 5 years, our labora-
tory has set out to use human pluripotent stem cells
(hPSCs) to model placental development in a dish [5].
“Pluripotent” stem cells have the ability to differentiate,
or turn into, any cell type in the body, including the pla-
cental cell type, “trophoblast”[6,7]. While initially hPSCs
had to be derived from human embryos, in 2007, Yama-
naka et al. developed a method for generating such cells
from any proliferative cell type [8]. hPSCs have now
been derived from numerous cell types, including
amnion cells of the placenta [9].
We have developed a method for step-wise differentia-
tion of such hPSCs, first into trophoblast precursor cells
and then into terminally differentiated, functional tro-
phoblast, including multinucleated syncytiotrophoblast
(STB) and invasive extravillous trophoblast (EVT).
These two cell types are the functional units of the pla-
centa: STB carry out nutrient and gas exchange, while
the EVT invade the maternal uterus and establish blood
flow to the feto-placental unit. Our differentiation
method is both reproducible and highly efficient, with
>95% of cells becoming trophoblast in the culture dish,
based both on expression of specific genes and on func-
tional assays such as secretion of the pregnancy hor-
mone, hCG. We recently applied this method to hPSCs
carrying a chromosomal aneuploidy, Trisomy 21 (T21).
It is known that trophoblast isolated from T21 placentas
have a defect in differentiation into multinucleated,
hCG-secreting STB [10]. We asked whether this defect
could be reproduced in culture when differentiating T21
hPSCs into trophoblast. We observed that T21 hPSCs
indeed show delayed differentiation into functional STB,
secreting significantly less hCG into the media com-
pared to trophoblast derived from hPSCs with a normal
karyotype. These results confirm the utility of hPSCs in
modeling human placenta, both during normal develop-
ment and in disease. We are currently collecting and
banking amnion epithelial cells from placentas of
patients with pregnancy complications, focusing on
early-onset severe preeclampsia, which is highly asso-
ciated with both maternal and neonatal morbidity and
mortality. We believe that, once reprogrammed into
hPSCs, these cells hold great promise, both in advancing
our understanding of the mechanisms of placental dys-
function, and also in providing a platform for drug
screening to reverse the disease phenotype.
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